Lincoln National Quarterly Balance Sheets Chart
Quarterly
|
Annual
Lincoln National Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2022-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||
| investments: | |||||||||||||||||||||||||||||
| fixed maturity available-for-sale securities, at fair value | 98,050,000,000 | ||||||||||||||||||||||||||||
| trading securities | 1,909,000,000 | 1,984,000,000 | 2,025,000,000 | 2,206,000,000 | 2,201,000,000 | 2,227,000,000 | 2,359,000,000 | 4,385,000,000 | 4,019,000,000 | 3,314,000,000 | 1,553,000,000 | 1,914,000,000 | 1,949,000,000 | 2,077,000,000 | 2,134,000,000 | 2,339,000,000 | 2,316,000,000 | 2,354,000,000 | 2,391,000,000 | 2,528,000,000 | 2,554,000,000 | 2,650,000,000 | 2,649,000,000 | 2,650,000,000 | 2,675,000,000 | 2,598 | 2,548,000,000 | 2,317,000,000 | 2,246,000,000 |
| equity securities | 341,000,000 | 345,000,000 | 294,000,000 | 293,000,000 | 295,000,000 | 319,000,000 | 306,000,000 | 346,000,000 | 83,000,000 | 153,000,000 | 112,000,000 | 242,000,000 | 227,000,000 | 210,000,000 | 234,000,000 | 256,000,000 | 207,000,000 | 185,000,000 | 209,000,000 | 148,000,000 | 157,000,000 | ||||||||
| mortgage loans on real estate, net of allowance for credit losses | |||||||||||||||||||||||||||||
| policy loans | 2,552,000,000 | 2,529,000,000 | 2,476,000,000 | 2,510,000,000 | 2,513,000,000 | 2,476,000,000 | 2,476,000,000 | 2,339,000,000 | 2,571,000,000 | 2,498,000,000 | 2,389,000,000 | 2,647,000,000 | 2,654,000,000 | 2,664,000,000 | 2,677,000,000 | 2,683,000,000 | 2,687,000,000 | 2,679,000,000 | 2,700,000,000 | 2,727,000,000 | 2,766,000,000 | 2,780,000,000 | 2,829,000,000 | 2,842,000,000 | 2,884,000,000 | 2,837 | 2,893,000,000 | 2,897,000,000 | 2,908,000,000 |
| derivative investments | 8,349,000,000 | 7,849,000,000 | 9,677,000,000 | 9,522,000,000 | 8,608,000,000 | 8,394,000,000 | 6,474,000,000 | 4,840,000,000 | 4,417,000,000 | 981,000,000 | 827,000,000 | 2,020,000,000 | 1,340,000,000 | 2,095,000,000 | 1,439,000,000 | 1,142,000,000 | 1,044,000,000 | 1,114,000,000 | 1,683,000,000 | 2,268,000,000 | 2,652,000,000 | 3,072,000,000 | 3,399,000,000 | 2,244,000,000 | 3,151,000,000 | 946 | 1,282,000,000 | 1,234,000,000 | 2,226,000,000 |
| other investments | 6,611,000,000 | 6,653,000,000 | 6,588,000,000 | 5,743,000,000 | 5,652,000,000 | 5,256,000,000 | 5,015,000,000 | 4,127,000,000 | 4,765,000,000 | 2,752,000,000 | 2,049,000,000 | 1,820,000,000 | 1,624,000,000 | 1,885,000,000 | 1,469,000,000 | 1,301,000,000 | 1,237,000,000 | 1,219,000,000 | 1,158,000,000 | 1,073,000,000 | 1,098,000,000 | 1,123,000,000 | 1,041,000,000 | 1,043,000,000 | 1,069,000,000 | 1,029 | 1,080,000,000 | 1,187,000,000 | 1,476,000,000 |
| total investments | 131,144,000,000 | 129,215,000,000 | 129,254,000,000 | 131,812,000,000 | 126,595,000,000 | 125,702,000,000 | 124,331,000,000 | 144,624,000,000 | 135,252,000,000 | 121,745,000,000 | 110,047,000,000 | 103,199,000,000 | 102,009,000,000 | 106,015,000,000 | 101,385,000,000 | 100,958,000,000 | 98,207,000,000 | 95,568,000,000 | 96,167,000,000 | 99,285,000,000 | 99,065,000,000 | 76,183,000,000 | 70,548,000,000 | 66,155,000,000 | |||||
| cash and invested cash | 7,143,000,000 | 4,284,000,000 | 5,801,000,000 | 6,013,000,000 | 5,475,000,000 | 4,122,000,000 | 3,365,000,000 | 1,960,000,000 | 6,202,000,000 | 1,593,000,000 | 2,257,000,000 | 3,772,000,000 | 2,327,000,000 | 3,487,000,000 | 1,821,000,000 | 1,509,000,000 | 1,849,000,000 | 2,650,000,000 | 2,574,000,000 | 3,107,000,000 | 4,230,000,000 | 4,373,000,000 | 5,257,000,000 | 3,516,000,000 | 4,510,000,000 | 2,216 | 3,161,000,000 | 2,539,000,000 | 5,613,000,000 |
| deferred acquisition costs, value of business acquired and deferred sales inducements | 12,604,000,000 | 12,563,000,000 | 12,537,000,000 | 12,475,000,000 | 12,435,000,000 | 12,405,000,000 | 12,397,000,000 | ||||||||||||||||||||||
| reinsurance recoverables, net of allowance for credit losses | 28,440,000,000 | 28,580,000,000 | 28,750,000,000 | 29,233,000,000 | 29,126,000,000 | 29,461,000,000 | 29,843,000,000 | 20,044,000,000 | 16,923,000,000 | ||||||||||||||||||||
| deposit assets, net of allowance for credit losses | 31,754,000,000 | 31,048,000,000 | 30,776,000,000 | 30,501,000,000 | 29,888,000,000 | 28,904,000,000 | 28,789,000,000 | ||||||||||||||||||||||
| market risk benefit assets | 4,577,000,000 | 4,157,000,000 | 4,860,000,000 | 4,565,000,000 | 4,754,000,000 | 4,878,000,000 | 3,894,000,000 | ||||||||||||||||||||||
| accrued investment income | 1,136,000,000 | 1,134,000,000 | 1,108,000,000 | 1,160,000,000 | 1,135,000,000 | 1,127,000,000 | 1,082,000,000 | 1,247,000,000 | 1,185,000,000 | 1,184,000,000 | 1,137,000,000 | 1,116,000,000 | 1,064,000,000 | 1,129,000,000 | 1,129,000,000 | 1,081,000,000 | 1,116,000,000 | 1,111,000,000 | 1,052,000,000 | 1,078,000,000 | 1,015,000,000 | 1,067,000,000 | 1,021,000,000 | 1,026,000,000 | 981,000,000 | 989 | 943,000,000 | 881,000,000 | 881,000,000 |
| goodwill | 1,144,000,000 | 1,144,000,000 | 1,144,000,000 | 1,144,000,000 | 1,144,000,000 | 1,144,000,000 | 1,144,000,000 | 1,778,000,000 | 1,778,000,000 | 1,778,000,000 | 1,368,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 2,273,000,000 | 3,019 | 3,096,000,000 | 3,344,000,000 | 3,344,000,000 |
| other assets | 8,181,000,000 | 8,267,000,000 | 8,163,000,000 | 8,454,000,000 | 8,782,000,000 | 9,413,000,000 | 9,311,000,000 | 17,406,000,000 | 16,246,000,000 | 16,373,000,000 | 6,313,000,000 | 3,450,000,000 | 3,647,000,000 | 2,901,000,000 | 3,414,000,000 | 3,760,000,000 | 3,822,000,000 | 2,709,000,000 | 2,655,000,000 | 2,569,000,000 | 2,580,000,000 | 2,502,000,000 | 2,475,000,000 | 2,486,000,000 | 2,536,000,000 | 3,293 | 10,827,000,000 | 9,982,000,000 | 3,396,000,000 |
| separate account assets | 172,942,000,000 | 162,506,000,000 | 168,438,000,000 | 171,483,000,000 | 165,199,000,000 | 166,225,000,000 | 158,257,000,000 | 168,879,000,000 | 130,617,000,000 | 143,369,000,000 | 142,761,000,000 | 120,275,000,000 | 128,079,000,000 | 127,828,000,000 | 122,937,000,000 | 124,159,000,000 | 118,968,000,000 | 109,376,000,000 | 102,783,000,000 | 101,366,000,000 | 95,373,000,000 | 93,326,000,000 | 88,839,000,000 | 91,088,000,000 | 83,477,000,000 | 88,236 | 70,111,000,000 | 61,091,000,000 | 57,487,000,000 |
| total assets | 399,065,000,000 | 382,898,000,000 | 390,831,000,000 | 396,840,000,000 | 384,533,000,000 | 383,381,000,000 | 372,413,000,000 | 365,929,000,000 | 318,649,000,000 | 314,299,000,000 | 279,237,000,000 | 249,532,000,000 | 255,214,000,000 | 258,485,000,000 | 248,446,000,000 | 249,125,000,000 | 241,949,000,000 | 229,924,000,000 | 223,321,000,000 | 224,341,000,000 | 218,869,000,000 | 181,490,000,000 | 167,045,000,000 | 157,427,000,000 | |||||
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||
| liabilities | |||||||||||||||||||||||||||||
| policyholder account balances | 129,209,000,000 | 125,262,000,000 | 126,197,000,000 | 125,968,000,000 | 124,113,000,000 | 122,300,000,000 | 120,737,000,000 | ||||||||||||||||||||||
| future contract benefits | 41,053,000,000 | 40,665,000,000 | 39,807,000,000 | 41,169,000,000 | 38,560,000,000 | 38,848,000,000 | 39,864,000,000 | 39,773,000,000 | 37,100,000,000 | 34,009,000,000 | 22,923,000,000 | 20,523,000,000 | 20,166,000,000 | 20,468,000,000 | 19,553,000,000 | 19,460,000,000 | 18,997,000,000 | 18,138,000,000 | 18,214,000,000 | 19,149,000,000 | 19,780,000,000 | 19,232,000,000 | 19,930,000,000 | 18,784,000,000 | 19,813,000,000 | 17,313 | 15,970,000,000 | 16,128,000,000 | 18,836,000,000 |
| funds withheld reinsurance liabilities | 16,700,000,000 | 16,838,000,000 | 16,907,000,000 | 17,595,000,000 | 17,044,000,000 | 17,486,000,000 | 17,641,000,000 | 2,164,000,000 | 1,843,000,000 | 1,762,000,000 | 1,726,000,000 | 676,000,000 | 718,000,000 | 717,000,000 | 806,000,000 | 842,000,000 | 843,000,000 | 898,000,000 | 926,000,000 | 926,000,000 | 940,000,000 | 987,000,000 | 999,000,000 | 1,043,000,000 | 1,045,000,000 | 1,135 | 1,220,000,000 | 1,222,000,000 | 1,215,000,000 |
| market risk benefit liabilities | 1,205,000,000 | 1,306,000,000 | 1,046,000,000 | 1,272,000,000 | 1,275,000,000 | 1,266,000,000 | 1,716,000,000 | ||||||||||||||||||||||
| deferred front-end loads | 7,119,000,000 | 6,910,000,000 | 6,730,000,000 | 6,517,000,000 | 6,306,000,000 | 6,099,000,000 | 5,901,000,000 | ||||||||||||||||||||||
| payables for collateral on investments | 8,466,000,000 | 8,282,000,000 | 10,020,000,000 | 10,570,000,000 | 11,114,000,000 | 10,117,000,000 | 8,105,000,000 | 8,927,000,000 | 8,434,000,000 | 5,362,000,000 | 4,265,000,000 | 5,297,000,000 | 4,587,000,000 | 5,046,000,000 | 3,853,000,000 | 3,571,000,000 | 3,519,000,000 | 3,553,000,000 | 4,252,000,000 | 4,107,000,000 | 4,181,000,000 | 4,566,000,000 | 5,070,000,000 | 2,875,000,000 | 3,733,000,000 | 1,554 | 2,240,000,000 | ||
| short-term debt | 300,000,000 | 300,000,000 | 450,000,000 | 503,000,000 | 250,000,000 | 300,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | 503,000,000 | 506,000,000 | 706,000,000 | 200,000,000 | 200,000,000 | 300,000,000 | 300,000,000 | 300,000,000 | 351 | 400,000,000 | 455,000,000 | 1,436,000,000 | |||||||
| long-term debt | 5,767,000,000 | 5,868,000,000 | 5,856,000,000 | 5,897,000,000 | 5,716,000,000 | 5,726,000,000 | 5,699,000,000 | 6,561,000,000 | 6,748,000,000 | 5,572,000,000 | 5,648,000,000 | 5,604,000,000 | 5,529,000,000 | 5,627,000,000 | 5,186,000,000 | 5,170,000,000 | 5,380,000,000 | 5,365,000,000 | 5,050,000,000 | 4,889,000,000 | 5,439,000,000 | 5,494,000,000 | 5,719,000,000 | 5,606,000,000 | 5,391,000,000 | 5,370 | 4,789,000,000 | 4,775,000,000 | 4,345,000,000 |
| other liabilities | 7,056,000,000 | 7,068,000,000 | 7,261,000,000 | 7,056,000,000 | 6,807,000,000 | 7,265,000,000 | 7,350,000,000 | 12,012,000,000 | 17,824,000,000 | 13,372,000,000 | 4,934,000,000 | 6,071,000,000 | 4,936,000,000 | 6,340,000,000 | 5,168,000,000 | 5,114,000,000 | 4,866,000,000 | 4,145,000,000 | 3,929,000,000 | 4,993,000,000 | 5,139,000,000 | 5,036,000,000 | 4,950,000,000 | 4,352,000,000 | 4,762,000,000 | 3,472 | 10,598,000,000 | 9,631,000,000 | 2,326,000,000 |
| separate account liabilities | 172,942,000,000 | 162,506,000,000 | 168,438,000,000 | 171,483,000,000 | 165,199,000,000 | 166,225,000,000 | 158,257,000,000 | 168,879,000,000 | 130,617,000,000 | 143,369,000,000 | 142,761,000,000 | 120,275,000,000 | 128,079,000,000 | 127,828,000,000 | 122,937,000,000 | 124,159,000,000 | 118,968,000,000 | 109,376,000,000 | 102,783,000,000 | 101,366,000,000 | 95,373,000,000 | 93,326,000,000 | 88,839,000,000 | 91,088,000,000 | 83,477,000,000 | 88,236 | 70,111,000,000 | 61,091,000,000 | 57,487,000,000 |
| total liabilities | 389,517,000,000 | 374,705,000,000 | 382,562,000,000 | 387,827,000,000 | 376,584,000,000 | 375,835,000,000 | 365,520,000,000 | 351,217,000,000 | 302,074,000,000 | 297,882,000,000 | 263,252,000,000 | 235,131,000,000 | 240,515,000,000 | 242,262,000,000 | 232,994,000,000 | 233,674,000,000 | 227,463,000,000 | 216,535,000,000 | 210,004,000,000 | 209,479,000,000 | 203,896,000,000 | 169,834,000,000 | 157,970,000,000 | 150,104,000,000 | |||||
| contingencies and commitments | |||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||
| preferred stock – 10,000,000 shares authorized: | |||||||||||||||||||||||||||||
| series c preferred stock – 20,000 shares authorized, issued and outstanding | |||||||||||||||||||||||||||||
| as of june 30, 2025, and december 31, 2024 | 493,000,000 | ||||||||||||||||||||||||||||
| series d preferred stock – 20,000 shares authorized, issued and outstanding | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 189,570,904 and 170,380,646 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2025, and december 31, 2024, respectively | 5,545,000,000 | ||||||||||||||||||||||||||||
| retained earnings | 7,409,000,000 | 6,810,000,000 | 7,645,000,000 | 6,049,000,000 | 6,691,000,000 | 5,887,000,000 | 4,778,000,000 | 8,876,000,000 | 8,500,000,000 | 8,679,000,000 | 8,052,000,000 | 6,358,000,000 | 6,286,000,000 | 6,077,000,000 | 5,834,000,000 | 5,513,000,000 | 5,228,000,000 | 4,753,000,000 | 4,487,000,000 | 4,238,000,000 | 4,044,000,000 | 3,873,000,000 | 3,493,000,000 | 3,191,000,000 | 4,126,000,000 | 4,243 | 3,234,000,000 | 3,101,000,000 | 3,265,000,000 |
| accumulated other comprehensive income | -4,392,000,000 | -4,306,000,000 | -5,036,000,000 | -2,682,000,000 | -4,369,000,000 | -3,951,000,000 | -3,476,000,000 | 1,250,000,000 | 3,004,000,000 | 2,453,000,000 | 2,233,000,000 | 1,663,000,000 | 1,944,000,000 | 3,653,000,000 | 2,922,000,000 | 3,199,000,000 | 2,453,000,000 | 1,750,000,000 | 1,893,000,000 | 3,581,000,000 | 3,808,000,000 | 4,150,000,000 | 3,379,000,000 | 2,622,000,000 | 2,448,000,000 | 783 | |||
| total stockholders’ equity | 9,548,000,000 | 8,193,000,000 | 8,269,000,000 | 9,013,000,000 | 7,949,000,000 | 7,546,000,000 | 6,893,000,000 | 14,712,000,000 | 16,575,000,000 | 16,417,000,000 | 15,985,000,000 | 14,401,000,000 | 14,699,000,000 | 16,223,000,000 | 15,452,000,000 | 15,451,000,000 | |||||||||||||
| total liabilities and stockholders’ equity | 399,065,000,000 | 382,898,000,000 | 390,831,000,000 | 396,840,000,000 | 384,533,000,000 | 383,381,000,000 | 372,413,000,000 | 365,929,000,000 | 318,649,000,000 | 314,299,000,000 | 279,237,000,000 | 249,532,000,000 | 255,214,000,000 | 258,485,000,000 | 248,446,000,000 | 249,125,000,000 | |||||||||||||
| as of march 31, 2025, and december 31, 2024 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 170,695,166 and 170,380,646 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2025, and december 31, 2024, respectively | 4,703,000,000 | ||||||||||||||||||||||||||||
| as of december 31, 2024, and december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 170,380,646 and 169,666,137 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of december 31, 2024, and december 31, 2023, respectively | 4,674,000,000 | ||||||||||||||||||||||||||||
| as of september 30, 2024, and december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 170,341,467 and 169,666,137 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of september 30, 2024, and december 31, 2023, respectively | 4,660,000,000 | ||||||||||||||||||||||||||||
| as of june 30, 2024, and december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 170,188,487 and 169,666,137 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2024, and december 31, 2023, respectively | 4,641,000,000 | ||||||||||||||||||||||||||||
| as of march 31, 2024, and december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 170,016,887 and 169,666,137 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2024, and december 31, 2023, respectively | 4,624,000,000 | ||||||||||||||||||||||||||||
| series c preferred stock – 20,000 shares authorized, issued and outstanding as of december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| series d preferred stock – 20,000 shares authorized, issued and outstanding as of december 31, 2023 | 493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 169,666,137 and 169,220,511 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of december 31, 2023, and december 31, 2022, respectively | 4,605,000,000 | ||||||||||||||||||||||||||||
| deferred acquisition costs and value of business acquired | 8,810,000,000 | 9,212,000,000 | 9,441,000,000 | 9,289,000,000 | 8,866,000,000 | 9,150,000,000 | 8,156,000,000 | 8,372,000,000 | 8,149,000,000 | 8,454,000,000 | 8,500,000,000 | 8,214,000,000 | 6,936,000,000 | 6,667,000,000 | 5,813,000,000 | 6,505,000,000 | 6,880,000,000 | 8,191,000,000 | 9,272 | 9,182,000,000 | 10,456,000,000 | 11,922,000,000 | |||||||
| premiums and fees receivable | 671,000,000 | 562,000,000 | 607,000,000 | 480,000,000 | 383,000,000 | 415,000,000 | 452,000,000 | 448,000,000 | 465,000,000 | 504,000,000 | 427,000,000 | 430,000,000 | 440,000,000 | 380,000,000 | 366,000,000 | 388,000,000 | 437,000,000 | 408,000,000 | 401 | 323,000,000 | 429,000,000 | 489,000,000 | |||||||
| funds withheld reinsurance assets | 510,000,000 | 535,000,000 | 549,000,000 | 576,000,000 | 639,000,000 | 642,000,000 | 646,000,000 | 761,000,000 | 764,000,000 | 772,000,000 | 782,000,000 | 788,000,000 | 798,000,000 | 837,000,000 | 846,000,000 | 863,000,000 | 866,000,000 | 874,000,000 | |||||||||||
| other contract holder funds | 112,901,000,000 | 99,508,000,000 | 93,959,000,000 | 80,710,000,000 | 76,451,000,000 | 76,243,000,000 | 75,663,000,000 | 74,893,000,000 | 74,735,000,000 | 74,507,000,000 | 74,106,000,000 | 73,830,000,000 | 72,760,000,000 | 72,218,000,000 | 70,706,000,000 | 70,422,000,000 | 70,027,000,000 | 69,466,000,000 | 67,125 | 63,956,000,000 | 62,427,000,000 | 61,525,000,000 | |||||||
| reinsurance-related embedded derivatives | |||||||||||||||||||||||||||||
| preferred stock – 10,000,000 shares authorized | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 171,890,974 and 177,193,515 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2022, and december 31, 2021, respectively | 4,586,000,000 | ||||||||||||||||||||||||||||
| reinsurance related embedded derivatives | 137,000,000 | 177,000,000 | 34,000,000 | 116,000,000 | 120,000,000 | 165,000,000 | 141,000,000 | 155,000,000 | 135,000,000 | 121,000,000 | 131,000,000 | 199,000,000 | 215,000,000 | 215,000,000 | 185,000,000 | 158,000,000 | 168,000,000 | 91 | 39,000,000 | ||||||||||
| common stock – 800,000,000 shares authorized; 193,208,244 and 196,668,532 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2020, and december 31, 2019, respectively | 5,071,000,000 | ||||||||||||||||||||||||||||
| mortgage loans on real estate | 13,997,000,000 | 11,047,000,000 | 8,431,000,000 | 8,171,000,000 | 7,654,000,000 | 7,466,000,000 | 7,096,000,000 | 7,089,000,000 | 7,127,000,000 | 7,033,000,000 | 7,057,000,000 | 7,029,000,000 | 6,690,000,000 | 6,804,000,000 | 6,938,000,000 | 6,942,000,000 | 6,749 | 7,277,000,000 | 7,468,000,000 | 7,616,000,000 | |||||||||
| reinsurance recoverables | 17,660,000,000 | 5,009,000,000 | 5,559,000,000 | 5,608,000,000 | 5,598,000,000 | 5,906,000,000 | 6,007,000,000 | 5,984,000,000 | 6,528,000,000 | 6,385,000,000 | 6,489,000,000 | 6,449,000,000 | 6,424,000,000 | 6,601,000,000 | 6,534,000,000 | 6,526,000,000 | 6,580 | 7,664,000,000 | 7,729,000,000 | 8,033,000,000 | |||||||||
| common stock – 800,000,000 shares authorized; 202,987,229 and 205,862,760 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2019, and december 31, 2018, respectively | 5,285,000,000 | ||||||||||||||||||||||||||||
| available-for-sale securities, at fair value: | |||||||||||||||||||||||||||||
| fixed maturity securities | 92,059,000,000 | 85,506,000,000 | 85,422,000,000 | 88,813,000,000 | 85,348,000,000 | 85,511,000,000 | 82,988,000,000 | 80,135,000,000 | 80,235,000,000 | 82,711,000,000 | 82,036,000,000 | ||||||||||||||||||
| real estate | 11,000,000 | 21,000,000 | 24,000,000 | 19,000,000 | 20,000,000 | 32,000,000 | 42,000,000 | 56,000,000 | 60,000,000 | 65,000,000 | 65,000,000 | 112,000,000 | 116,000,000 | 113,000,000 | 137,000,000 | 189 | 154,000,000 | 159,000,000 | 129,000,000 | ||||||||||
| deferred gain on business sold through reinsurance | 1,000,000 | 116,000,000 | 134,000,000 | 153,000,000 | 190,000,000 | 208,000,000 | 226,000,000 | 263,000,000 | 282,000,000 | 301,000,000 | 319,000,000 | 338,000,000 | 356,000,000 | 375,000,000 | 394,000,000 | 450 | 511,000,000 | 529,000,000 | 548,000,000 | ||||||||||
| common stock – 800,000,000 shares authorized; 218,695,476 and 218,090,114 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2018, and december 31, 2017, respectively | 5,700,000,000 | ||||||||||||||||||||||||||||
| variable interest entities’ fixed maturity securities | 598,000,000 | 598,000,000 | 598,000,000 | 598,000,000 | 598,000,000 | ||||||||||||||||||||||||
| variable interest entities’ liabilities | 2,000,000 | 3,000,000 | 5,000,000 | 17,000,000 | 10,000,000 | ||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 247,464,931 and 256,551,440 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of september 30, 2015, and december 31, 2014, respectively | 6,380,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 250,918,893 and 256,551,440 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2015, and december 31, 2014, respectively | 6,469,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 252,928,502 and 256,551,440 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2015, and december 31, 2014, respectively | 6,493,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 259,786,446 and 262,896,701 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of september 30, 2014, and december 31, 2013, respectively | 6,696,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 260,831,708 and 262,896,701 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2014, and december 31, 2013, respectively | 6,739,000,000 | ||||||||||||||||||||||||||||
| variable interest entities' fixed maturity securities | 597,000,000 | 699,000,000 | 698,000,000 | 708,000,000 | 708,000,000 | ||||||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||
| variable interest entities' liabilities | 22,000,000 | 67,000,000 | 101,000,000 | 83,000,000 | 92,000,000 | 121,000,000 | 158,000,000 | 149,000,000 | 193,000,000 | 130 | |||||||||||||||||||
| stockholders' equity | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 263,682,162 and 262,896,701 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2014, and december 31, 2013, respectively | 6,805,000,000 | ||||||||||||||||||||||||||||
| total stockholders' equity | 14,486,000,000 | 13,389,000,000 | 13,317,000,000 | 14,862,000,000 | 14,973,000,000 | 11,656,000,000 | 9,075,000,000 | 7,323,000,000 | |||||||||||||||||||||
| total liabilities and stockholders' equity | 241,949,000,000 | 229,924,000,000 | 223,321,000,000 | 224,341,000,000 | 218,869,000,000 | 181,490,000,000 | 167,045,000,000 | 157,427,000,000 | |||||||||||||||||||||
| preferred stock – 10,000,000 shares authorized; series a – 9,532 shares issued and | |||||||||||||||||||||||||||||
| outstanding as of december 31, 2012 | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 262,342,363 and 271,402,586 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of september 30, 2013, and december 31, 2012, respectively | 6,886,000,000 | ||||||||||||||||||||||||||||
| preferred stock – 10,000,000 shares authorized; series a – 4,164 and 9,532 | |||||||||||||||||||||||||||||
| shares issued and outstanding as of june 30, 2013, and december 31, 2012, respectively | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 264,316,340 and 271,402,586 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2013, and december 31, 2012, respectively | 6,937,000,000 | ||||||||||||||||||||||||||||
| preferred stock – 10,000,000 shares authorized; series a – 9,532 shares issued and outstanding as of march 31, 2013, and december 31, 2012 | |||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 268,457,558 and 271,402,586 shares issued and outstanding as of march 31, 2013, and december 31, 2012, respectively | 7,043,000,000 | ||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized; series a - 9,532 and 10,072 shares issued and outstanding as of december 31, 2012, and december 31, 2011, respectively | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 271,402,586 and 291,319,222 shares issued and outstanding as of december 31, 2012, and december 31, 2011, respectively | 7,121,000,000 | ||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized; series a - 9,532 and 10,072 sharesissued and outstanding as of september 30, 2012, and december 31, 2011, respectively | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 275,073,618 and 291,319,222 shares issued and outstanding as of september 30, 2012, and december 31, 2011, respectively | 7,214,000,000 | ||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized; series a - 9,632 and 10,072 shares issued and outstanding as of june 30, 2012, and december 31, 2011, respectively | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 279,168,971 and 291,319,222 shares issued and outstanding as of june 30, 2012, and december 31, 2011, respectively | 7,310,000,000 | ||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized; series a - 9,632 and 10,072 shares | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 285,412,303 and 291,319,222 shares | |||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized; series a - 10,072 and 10,914 shares issued and outstanding as of december 31, 2011, and december 31, 2010, respectively | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 291,319,222 and 315,718,554 shares issued and outstanding as of december 31, 2011, and december 31, 2010, respectively | 7,590,000,000 | ||||||||||||||||||||||||||||
| preferred stock - 10,000,000 shares authorized: | |||||||||||||||||||||||||||||
| series a preferred stock - 10,914 and 10,914 shares issued and outstanding | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 313,456,824 and 315,718,554 shares | |||||||||||||||||||||||||||||
| fixed maturity | 60,666,000,000 | 55,050,000,000 | 49,349,000,000 | ||||||||||||||||||||||||||
| equity | 283,000,000 | 236,000,000 | 205,000,000 | ||||||||||||||||||||||||||
| series a preferred stock – 10,000,000 shares authorized; 11,547 and 11,562 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of september 30, 2009, and december 31, 2008, respectively | 7,842,000,000 | ||||||||||||||||||||||||||||
| series b preferred stock – 950,000 shares authorized and outstanding | |||||||||||||||||||||||||||||
| as of september 30, 2009 | 800,000,000 | ||||||||||||||||||||||||||||
| common stock – 800,000,000 shares authorized; 302,073,869 and 255,869,859 shares | |||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -220,000,000 | -1,707,000,000 | -2,975,000,000 | ||||||||||||||||||||||||||
| reinsurance related derivative assets | 46,000,000 | 107,000,000 | |||||||||||||||||||||||||||
| payables for collateral under securities loaned and derivatives | 1,712,000,000 | 2,386,000,000 | |||||||||||||||||||||||||||
| series a preferred stock - 10,000,000 shares authorized | |||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 302,093,017 and 255,869,859 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of june 30, 2009, and december 31, 2008, respectively | 7,681,000,000 | ||||||||||||||||||||||||||||
| common stock - 800,000,000 shares authorized; 256,046,103 and 255,869,859 shares | |||||||||||||||||||||||||||||
| issued and outstanding as of march 31, 2009, and december 31, 2008, respectively | 7,033,000,000 |
We provide you with 20 years of balance sheets for Lincoln National stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Lincoln National. Explore the full financial landscape of Lincoln National stock with our expertly curated balance sheets.
The information provided in this report about Lincoln National stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.